Replimune Group Inc (REPL)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current REPL market cap is 777.81M. The company's latest EPS is USD -3.2080 and P/E is -3.05.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -58.76M | -57.37M | -58.92M | -66.02M | -79.33M |
| Net Income | -55.08M | -53.77M | -53.06M | -66.34M | -74.13M |
| Year End March 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -79.96M | -118.31M | -177.08M | -234.77M | -261.63M |
| Net Income | -80.87M | -118.04M | -174.28M | -215.79M | -247.3M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 487.72M | 534.97M | 498.2M | 603.63M | 551.33M |
| Total Liabilities | 113.21M | 108.51M | 116.74M | 121.25M | 135.49M |
| Total Equity | 374.51M | 426.45M | 381.46M | 482.37M | 415.84M |
| Year End March 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 543.1M | 461.19M | 646.59M | 487.72M | 551.33M |
| Total Liabilities | 44.37M | 49.96M | 91.3M | 113.21M | 135.49M |
| Total Equity | 498.73M | 411.23M | 555.29M | 374.51M | 415.84M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -185.47M | -49.17M | -87.81M | -138.52M | -192.25M |
| Investing | 97.2M | 29.77M | 30.22M | -16.1M | -23.8M |
| Financing | 16.28M | 96.64M | 96.6M | 252.53M | 252.4M |
| Year End March 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -61.39M | -82.18M | -128.05M | -185.47M | -192.25M |
| Investing | -188.78M | -1.81M | -142.5M | 97.2M | -23.8M |
| Financing | 372.46M | 6.6M | 311.3M | 16.28M | 252.4M |
| Market Cap | 777.81M |
| Price to Earnings Ratio | -3.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.78 |
| Price to Book Ratio | 1.81 |
| Dividend Yield | - |
| Shares Outstanding | 77.09M |
| Average Volume (1 week) | 1.14M |
| Average Volume (1 Month) | 1.58M |
| 52 Week Change | 9.44% |
| 52 Week High | 16.52 |
| 52 Week Low | 6.44 |
| Spread (Intraday) | 0.55 (5.42%) |
| Company Name | Replimune Group Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.replimune.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
